Molecular Cancer Therapeutics CTRC-AACR San Antonio Breast Cancer Symposium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

About the Cover

Cover Figure


The Cover

Characterization of XIST (inactive X chromosome specific transcripts) in the ovarian carcinoma cell line SKOV3. Cytogenetic studies by spectral karyotyping (top panel) and X chromosome painting (middle panel, green) demonstrated that this cell line has five copies of X chromosomes. RNA FISH showed that the cell line consists of two populations of cells with one or two X chromosomes expressing XIST, respectively (bottom panel, green). Identified in an expression profiling between primary and recurrent ovarian tumors from the same patient, XIST expression was found to be significantly related to the taxol sensitivity in ovarian cancer cell lines and to the disease-free periods of ovarian cancer patients after chemotherapy. For details, see Huang et al. in this issue.



[Table of Contents]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 2004 by the American Association for Cancer Research.